LUDG — LUDWIG ENTERPRISES, INC.
—
OTC ·
Health Care ·
Health Care Providers & Services ·
CIK 1960262 ·
Last close
$0.00
Market Cap
$835.8K
52W High
$0.08
52W Low
$0.00
ADV30
10,417
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -564,979 | 218,847 | 1,264,572 | 18,323 | 5,293,267 |
| Dec 2025 | 0 | — | -292,773 | -1,077,298 | 247,527 | 0 | 4,635,733 |
| Sep 2025 | 0 | — | -371,364 | 31,252 | 261,594 | 3,317 | 3,572,502 |
| Jun 2025 | 0 | — | -585,622 | -649,444 | 401,274 | 142,474 | 3,803,434 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-707,939
Investing CF
$-8,546
Financing CF
$718,857
CapEx
$-8,546
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-09-06
Balance + Analyst (yfinance extras)
Retained Earnings
$-9,276,952
Inventory
$4,529
Receivables
$106,000
ST Investments
—
EBIT TTM
$-371,041
Pretax Income TTM
$-1,476,643
Interest Exp TTM
$1,105,602
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -1,774,680 | -2,236,433 | 247,527 | 4,635,733 | -4,388,206 | -644,842 |
| Dec 2024 | 217 | -1,298,189 | -3,016,884 | 197,556 | 2,575,701 | -2,378,145 | -660,302 |
| Dec 2023 | 0 | -1,375,761 | -2,456,550 | 112,468 | 1,574,033 | -1,461,565 | -647,860 |
| Dec 2022 | 0 | -560,505 | -965,150 | 516,195 | 1,342,362 | -826,167 | -444,805 |
TTM Snapshot
Revenues TTM
$4,000
NetIncome TTM
$-1,476,643
OpCashFlow TTM
—
Assets (Latest)
$1,264,572
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CDIX | Cardiff Lexington Corp | $938.2K | $0.06 | — |
| ATPC | Agape ATP Corp | $2.11M | $2.11 | — |
| FCHS | First Choice Healthcare Solutions, Inc. | $296.6K | $0.01 | — |
| BRTX | BioRestorative Therapies, Inc. | $2.61M | $1.89 | — |
| BGLC | BioNexus Gene Lab Corp | $3.66M | $1.25 | — |
Recent Insider Activity
No insider activity indexed for this ticker.